Monday, September 10, 2012
Memorial Sloan Kettering has announced its intention to build a new, state-of-the-art outpatient cancer treatment facility on Manhattan’s Upper East Side.
Memorial Sloan Kettering President and CEO Craig B. Thompson and New York Mayor Michael R. Bloomberg announced at a joint press conference earlier today that the institution plans to build a new outpatient cancer care facility on the Upper East Side of Manhattan. Pending regulatory approval, the 750,000-square-foot building will be on a site located between East 73rd and East 74th Streets along the FDR Drive, within blocks of its main campus.
Memorial Sloan Kettering purchased the property from the New York City Economic Development Corporation (NYCEDC) in collaboration with Hunter College of The City University of New York (CUNY), and the two institutions will jointly develop it. The complex will house Memorial Sloan Kettering’s outpatient facility along with Hunter College’s new 336,000-square-foot Science and Health Professions building.
Current plans for Memorial Sloan Kettering’s portion of the site are to provide care for patients with lung, head and neck, and hematologic cancers. The facility will include a state-of-the-art outpatient bone marrow transplantation program and other services. It will also allow the development of additional treatment programs that will make Memorial Sloan Kettering’s expertise available to more patients, improve clinical outcomes, reduce the costs of providing high-quality cancer care, and meet what is expected to be a growing demand for Memorial Sloan Kettering’s services as the population ages.
“This new facility will play a critically important role in our overall cancer care delivery system,” Dr. Thompson says. “It will have a patient-oriented physical design, making their experience as streamlined and easy as possible. It will also offer our physicians and other healthcare professionals an inspiring and efficient environment in which to provide care. And because of the physical proximity to our main hospital, there will be cohesiveness among all our departments. We are fortunate to live in a time of enormous opportunities to bring novel and more-effective treatments to patients with cancer. This new component of our clinical enterprise will touch many lives and extends Memorial Sloan Kettering’s historic commitment to the control and eventual cure of cancer.”
“Thanks to our innovative approach to economic development, today’s announcement is yet another step towards making New York City home to the world’s most talented workforce,” adds Mayor Bloomberg. “Not only will these two great institutions play a critical role in creating great jobs in one of the city’s growing industries, helping lure the globe’s best and brightest, but they will pave the way for ushering in the innovators and medical advancements of tomorrow.”
Dr. Thompson also notes that “we’re looking forward to many opportunities for collaboration between our clinicians and scientists and Hunter’s researchers and health science professionals.” In addition, he says that Hunter College’s School of Nursing, which will be part of the new complex, “will allow synergies between their students and our nurses. These interactions will have enormous benefits for both institutions, as well as for patients with cancer.”
Dr. Thompson and Mayor Bloomberg were joined at the press conference, held in Memorial Sloan Kettering’s Rockefeller Research Laboratories building, by Memorial Sloan Kettering’s Chief of the Adult Bone Marrow Transplant Service Sergio A. Giralt, CUNY Vice Chancellor for Facilities Planning, Construction & Management Iris Weinshall, New York City Economic Development Corporation President Seth W. Pinsky, New York City Department of Sanitation Commissioner John J. Doherty, and Hunter College President Jennifer Raab.